Advertisement
Advertisement
CODX
Co-Diagnostics, Inc. Common Stock
0.44
USDSponsored
0.00
+0.39%
Oct 29, 10:30 UTC -4
Open
Co-Diagnostics, Inc. Common Stock (CODX) Earnings
CODX Earnings Reports
Positive Surprise Ratio
CODX beat 17 of 31 last estimates.
55%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$172.38K
/-$1.27
Implied change from Q2 26 (Revenue/ EPS)
+3.84%
/-13.01%
Implied change from Q3 25 (Revenue/ EPS)
+18.88%
/-73.54%
Co-Diagnostics, Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, CODX reported earnings of -1.46 USD per share (EPS) for Q2 26, beating the estimate of -3.06 USD, resulting in a 52.29% surprise. Revenue reached 166.00 thousand, compared to an expected 169.83 thousand, with a -2.26% difference. The market reacted with a -6.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -1.27 USD, with revenue projected to reach 172.38 thousand USD, implying an decrease of -13.01% EPS, and increase of 3.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.93
Actual
$2.11
Surprise
+8.99%
HCA Healthcare, Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$6.72
Actual
$7.22
Surprise
+7.29%
Elevance Health, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.72
Actual
$6.99
Surprise
+47.81%
Labcorp Holdings Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$4.79
Actual
$4.78
Surprise
-0.31%
Medpace Holdings, Inc. Common Stock
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.52
Actual
$4.84
Surprise
+6.98%
Icon Plc
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.65
Actual
$2.66
Surprise
+0.27%
Avantor, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.21
Actual
$0.22
Surprise
+3.92%
Bausch + Lomb Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.22
Actual
$0.34
Surprise
+53.43%
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
Establishment Labs Holdings Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.35
Surprise
-33.69%
FAQ
What were Co-Diagnostics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Co-Diagnostics, Inc. Common Stock reported EPS of -$1.46, beating estimates by 52.29%, and revenue of $166.00K, -2.26% below expectations.
How did the market react to Co-Diagnostics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -6.04%, changed from $1.49 before the earnings release to $1.40 the day after.
When is Co-Diagnostics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Co-Diagnostics, Inc. Common Stock's next earnings report?
Based on 4
analysts, Co-Diagnostics, Inc. Common Stock is expected to report EPS of -$1.27 and revenue of $172.38K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.